3 names to watch on biotech beatdown By: CNBC.com News August 20, 2015 at 18:42 PM EDT The cholesterol drug space is set to get more crowded, and "Fast Money" traders believe one biotech company should benefit most. Read More >> Related Stocks: Amgen Nasdaq Biotechnology Ishares ETF Regeneron Pharmaceuticals